ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GENF Genflow Biosciences Plc

2.05
0.00 (0.00%)
May 02 2024 - Closed
Delayed by 15 minutes

Genflow Biosciences Financial Summary

The current GENF market cap is 6M. The company's latest EPS is GBP -0.0046 and P/E is -4.46.

Year End December 30 2022 202120212022
GBP (£)GBP (£)GBP (£)
Total Revenue 00487k
Operating Income -109k-459k-909k
Net Income -109k-988k-1.34M
Year End December 30 2022 202120212022
GBP (£)GBP (£)GBP (£)
Total Assets 284k277k2.62M
Total Liabilities 65k222k251k
Total Equity 219k55k2.37M

Cash Flow

Year End December 30 2022 202120212022
GBP (£)GBP (£)GBP (£)
Operating -73k-747k-1.37M
Investing N/A 199k-2k
Financing 327k784k3.5M
Market Cap 6M
Price to Earnings Ratio -4.46
Price to Sales Ratio 12.06
Price to Cash Ratio 2.53
Price to Book Ratio 2.53
Dividend Yield -

Share Statistics

Shares Outstanding 292.51M
Average Volume (1 week) 2.92M
Average Volume (1 Month) 1.65M
52 Week Change -49.38%
52 Week High 4.05
52 Week Low 1.35
Spread (Intraday) 0 (0%)

Company Info

Company Name Genflow Biosciences Plc
Address 6 heddon street
london W1B 4BT
Website https://www.genflowbio.com
Industry coml physical, biologcl resh (8731)

Your Recent History

Delayed Upgrade Clock